Cryogenic Society of America Corporate Sustaining Member logo                           

 

...........

 

Mesuron LLC

 Taking the art of  bio-magnetic

                    Measurements to the next

                                Revolutionary level!

 

...........

     

  Home Contact Us News Bibliography Product Medical.Adv. Board Clinical Value Business Adv. Board About Us

 

 

Scientific and Medical Advisory Board

 Riccardo Fenici, MD, PhD

 

Dr. Riccardo Fenici is specialist in Cardiology and in Vascular Surgery.

He is Associate Professor of Cardiology and Director of the Clinical Physiology - Biomagnetism Clinical Research Center, at the Catholic University of Sacred Heart (UCSC) in Rome (Italy).

His research extends in Clinical Electrophysiology, Monophasic Action Potential recording, Computer ECG Analysis, High Resolution ECG, Clinical and Experimental  Magnetocardiography, Magnetic Cardiac Mapping and Multimodal Cardiac Imaging of cardiac electrophysiology for non-invasive preoperative localization of arrhythmogenic substrates, Magnetocardiographic detection of myocardial ischemia. He has also studied risk assessment in WPW patients, Autoimmunity against β-adrenoceptors in patients with silent cardiomyopathy and "idiopathic" arrhythmias, Autonomic Nervous System and Heart Rate Variability. Police Stress.

Since 1979, as Consultant Cardiologist for Magnetocardiography and Electrophysiology at the Italian National Research Council (CNR), Consultant Cardiologist at the PTB, Institute of Berlin (D), Consultant cardiologist for Clinical Magnetocardiography within US National Science Foundation Small Business Innovation Research (SBIR) project [Phase II], has deeply contributed to the development and progress of clinical Magnetocardiography.

Has been national coordinator of three strategic national projects of the Italian Ministry of University and Research  on “Clinical Validation of Magnetocardiography for the electroanatomical imaging of cardiac arrhythmias” granting the development, in collaboration with CardioMag Inc., of the first 36-channel system for unshielded Magnetocardiography in a cardiac catheterization laboratory, installed at the Clinical Physiology - Biomagnetism Clinical Research Center of the Catholic University of Rome, in 2002.

Is inventor of the "Biomagnetically Guided Method For Catheter Ablation Of Cardiac Arrhythmias" and a MCG Mapping Technique under Cardiac Pacing as a calibration method to quantify the accuracy and reliability of MCG functional localization of cardiac sources, [US Patent 5,056,517 (1991)], and of several others patents in the same field: European patent n. 0428 812A1, (1991); Japan Utility Model n. 2554105 released (1997); PCT/IT99/00402 PCT PUB.NO. WO00/33734 PCT PUB. (2000); US Patent 6,527,724, (2003); Australian Patent: # 766302 (2004); “Catheter guidance by magnetocardiographic mapping” Eur. Patent Application 99 959 681.0 – 2305 (2007).

Dr. Fenici is also the founder and local coordinator of the Doctorate school in “New Advanced Technologies for Clinical Physiology and Multimodal Cardiac Imaging”, at the Catholic University of Sacred Heart.

Has been invited visiting scientist at the PTB, Institute of Berlin (D), and at the Helsinki University of Technology and Helsinki University Central Hospital, University, for research in Cardiomagnetism, within the BIRCH Program of the European Community. Has been invited lecturer at the Fysisk Institut of Danemarks Tekniske Universitetet; at the PTI Akademie der Wissenschaften der DDR and at the Department of Physics, Dalhousie University, Halifax, Nova Scotia, Canada.

Dr. Fenici has authored more than 150 scientific publications in peer-review journals,  more than  50 of them on Clinical and Experimental Magnetocardiography. 

See publication references here >>

Websites: http://docenti.unicatt.it/web/profilo.do?cod_docente=1000063586&language=ITA&section=profilo

 

 

 Steven M. Schwarz, MD, FAAP, FACN, AGAF,

Received his BA from Yale College, his MD from Columbia University College of Physicians and Surgeons, and his post-doctoral training in Pediatric Gastroenterology and Nutrition at Stanford and Columbia Universities. He served on the faculty of the Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine from 1980-1984, and at New York Medical College from 1984-1995, where he was the recipient of the Charles H. Revson Foundation Career Scientist Award, and where he subsequently served both as Chief of the Division of Pediatric Gastroenterology and Nutrition and as Director of the Graduate Program in Nutrition. In 1995, he was named Distinguished Lecturer in the Graduate School of Health Sciences at New York Medical College. Since 1995, he has been a tenured Professor of Pediatrics at the State University of New York Downstate Medical Center, where he is Director of the Division of Pediatric Gastroenterology, Hepatology and Nutrition. Dr. Schwarz is past Chair of the Clinical Care and Quality Committee and the Ethics Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, and he is currently Vice-Chair of the Institutional Review Board of the Biomedical Research Alliance of New York. He is a Fellow of the American Academy of Pediatrics, the American Pediatric Society, the American Gastroenterological Association and the New York Academy of Medicine. Dr. Schwarz has published more than 150 original papers, abstracts and book chapters, covering a wide array of both basic research and clinical topics in pediatric gastroenterology and nutrition.

 

 

Donatella Brisinda MD, PhD

 Dr. Donatella Brisinda, Board certified specialist in Internal Medicine with more than 15 year of experience in Cardiology and clinical electrophysiology, has got her European Ph.D. in “New advanced technologies in Clinical Physiology and Multimodal Cardiac Imaging” and a second level Master in “Clinical Electrophysiology and Cardiac pacing” at the Catholic University of Sacred Heart (UCSC) in Rome.

She is Medical Director (level 1), Assistant professor of Internal Medicine and Vice Director of the Clinical Physiology - Biomagnetism Clinical Research Center at UCSC.

Her research work extends in Clinical and Experimental Magnetocardiography, Magnetic Cardiac Mapping and Multimodal Cardiac Imaging, Magnetocardiographic detection of myocardial ischemia, Risk assessment in WPW patients, Atrial Fibrillation, Autoimmunity, Autonomic Nervous System assessment in movement disorders, Heart Rate Variability and Police Stress. She has also participated as clinical investigator in the “ARISTOTLE Trial”

She is Member of the European Society of Cardiology, of European Heart Rhythm Association (EHRA), of the “International Society of Electrocardiology” and of The Society for Police an Criminal Psychology.

Dr. Brisinda has been invited speakers in international conferences on Biomagnetism, Cardiology and Police Psychology and is author or co-author of more than 70 publications in peer-reviewed journals.

 

Dr. Eugene D. Kaplan is a diplomat of the Board of American Academy of Psychiatry and Neurology, American Board of Interventional Pain Physicians, Board of Headache Medicine, Board of Vascular Neurology and a Fellow of Interventional Pain Physicians. As pain is a function of the Central Nervous System, dual expertise in Neurology and Pain Management creates a comprehensive approach to the patient. 
 

Dr. Eugene D. Kaplan is a President and a Medical Director of Neurological and Stroke Care, PLLC and a Medical Director of Comprehensive Pain Management Center and Headache and Facial Pain Treatment Center divisions serving patients in Albany and the Capital Region.

He originally graduated from Kuibyshev Medical School in Samara, Russia as a general surgeon with a consequent sub-specialization in intensive care andanesthesia. He moved to the United States in 1993 with a 10 year experience working in the areas of his expertise. His medical positions included an Attending Physician in the Intensive Care Unit at the Regional Toxicology Center, Attending Physician in a Hyperbarooxygenotherapy Department, Attending Physician and Chief of the Intensive Care Department at a Cardio-Pulmonary hospital. In spite of his multiple responsibilities he was also teaching in the Nursing Education Program and teaching and supervising of medical students.

Upon his arrival to the US he first did his training at the Neurology Residency Program at Albany Medical Center. He was awarded the “Excellence in Neurological Physical Examination” Award at the Residency Program in 1999. During his senior year he served as a Chief Resident and a Journal Club Leader. After graduation from the Residency Program he completed a two year fellowship at Columbia University where he also worked as an attending physician at a Stroke Center in addition to being a Post-Doctoral Epidemiology Fellow and Post-Doctoral Research Fellow. He was actively involved in teaching and supervision of Neurology Residents. During his fellowship years he also earned a combined double degree of Master in Public Health from Columbia University – one in “Epidemiology and Clinical Research” and another in “Health Care Policy and Management”.

Dr. Kaplan has always been involved in medical research. Being a medical student, he started investigating new organic compounds for carcinogenic activity as a research technician at the Toxicology Research Laboratory, Kuibyshev Medical Institute, Kuibyshev, Russia. He soon co-founded an Experimental Oncology Interdisciplinary Research Group at the Department of Pathophysiology, Kuibyshev Medical Institute, Kuibyshev, Russia. As a fellow at the Columbia University, Dr. Eugene Kaplan participated in the North Manhattan Stroke Study (NOMASS) as a Research Fellow. The results of his research were presented at Neurological and Stroke meetings in the USA and Europe.

At Columbia-Presbyterian Medical Center he was also a co-investigator in clinical trials, including Aortic Plaque in Stroke Study (APRIS), Multi-Ethnic Study of Atherosclerosis (MESA), Hemicraniectomy and Durotomy for Deterioration From Infarction Relating Swelling Trial (HeaDDFIRST) Study, ARGatroban Injection in patients with acute ischemic Stroke (ARGIS-1) Study, Management of Atherothrombosis with Clopidogrel in High-risk patients with recent TIA or ischemic stroke (MATCH) Study and AMPA Receptor Antagonist Treatment in Ischemic Stroke Trial (ARTIST) Study. He was also the principle investigator for the Stroke Educational Program Impact Study (SEPIS), St. Clare’s Hospital, Schenectady, NY.

Dr. Kaplan is a member of many professional societies:

  • American Academy of Neurology

  • American Headache Society

  • American Neuromodulation Society

  • American Society of Interventional Pain Physicians

  • American Society of Regional Anesthesia

  • American Society of Neuroimaging

  • American Stroke Association

  • Epilepsy Foundation

  • International Spine Intervention Society

  • Restless Legs Syndrome Foundation

  • World Institute of Pain

Dr. Kaplan is an editor on Editorial Board of “Pain Physician” journal. He served as a reviewer of manuscripts for the American Heart Association “Stroke” journal. Dr. Kaplan is a member of the Professional Advisory Board of Epilepsy Foundation of Upstate New York. He is also a member of the Interventional Headache Treatment Group of American Headache Society and of the Stroke Council of American Stroke Association.

 

 

 

Yuri Polyakov, PhD

 

Dr. Polyakov is a Senior Research Scientist at the State University of New York (SUNY) at Stony Brook. He received his Ph.D. degree in 1983 from the Moscow Institute of Physics and Technology, one of the world’s leading universities in the field of experimental physics. He is the author of more than 25 publications in scientific journals, 14 conference proceedings and 3 patents. During his 25 years as an experimental physicist and engineer, Dr. Polyakov has been a principle developer of various sophisticated scientific methods and devices in the fields of semiconductor science, superconductor electronics, laser-optical diagnostics of biological objects, spectroscopy of atmospheric gases and super sensitive magnetic measurements. Since 1997 he has also been the owner of a company Research & Development Inc. dedicated to the development of electronic devices used in unique scientific and industrial applications. One of his products, a multi-channel measurement setup for the screening of superconductor chips, is used as the standard test equipment in the leading fabrication facilities worldwide.

 

Dr. Polyakov's public profile at LinkedIn: http://www.linkedin.com/pub/yuri-polyakov/8/b16/5b5

 

 

 

Michael Gurvitch, PhD

 

Dr. Gurvitch is a tenured professor of physics at the State University of New York (SUNY) at Stony Brook. Prior to joining the SUNY in 1990, Dr. Gurvitch was a scientist at the AT&T Bell Labs.

He has authored and co-authored over 100 publications and is well known for his expertise in metal physics and superconductivity.

 

 

 

Cryogenic Society of America Corporate Sustaining Member logo

 

 
     
 

Disclaimer
Mesuron LLC All rights reserved 2011